$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Divisible tablet having controlled and delayed release of the active substance 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-009/20
  • A61K-009/22
  • A61K-009/24
  • A61K-009/28
출원번호 US-0177028 (1980-08-11)
우선권정보 CH-0007514 (1979-08-16); CH-0003959 (1980-05-21)
발명자 / 주소
  • Hess Hans (Binningen CHX) Voellmy Carlo (Rheinfelden CHX)
출원인 / 주소
  • Ciba-Geigy Corporation (Ardsley NY 02)
인용정보 피인용 횟수 : 61  인용 특허 : 1

초록

Divisible tablet having controlled and delayed release of the active substance and consisting of a compact that is optionally provided with a coating and is formed by at least one active substance in an adjunct composition that effects a delayed and controlled release of the active substance and opt

대표청구항

A divisible tablet having controlled and delayed release of the active substance, characterised in that it consists of a compact, with or without a coating having no influence on the release of said active substance, said compact being formed by pressing a granulate of at least one active substance

이 특허에 인용된 특허 (1)

  1. Ullman Michael K. (Evansville IN) David Stephen T. (Evansville IN) Gallian Claude E. (Evansville IN), Multi-fractionable tablet structure.

이 특허를 인용한 특허 (61)

  1. Arkenau-Maric, Elisabeth; Bartholomaus, Johannes; Kugelmann, Heinrich, Abuse-proof dosage form.
  2. Arkenau-Maric, Elisabeth; Bartholomaeus, Johannes; Kugelmann, Heinrich, Abuse-proofed dosage form.
  3. Arkenau-Maric, Elisabeth; Bartholomaeus, Johannes; Kugelmann, Heinrich, Abuse-proofed dosage form.
  4. Arkenau-Maric, Elisabeth; Bartholomäus, Johannes; Kugelmann, Heinrich, Abuse-proofed dosage form.
  5. Arkenau-Maric, Elisabeth; Bartholomäus, Johannes; Kugelmann, Heinrich, Abuse-proofed dosage form.
  6. Bartholomaeus, Johannes; Kugelmann, Heinrich, Abuse-proofed dosage form.
  7. Bartholomaus, Johannes; Kugelmann, Heinrich; Arkenau-Marić, Elisabeth, Abuse-proofed dosage form.
  8. Bartholomäus, Johannes; Kugelmann, Heinrich; Arkenau-Marić, Elisabeth, Abuse-proofed dosage form.
  9. Bartholomäus, Johannes; Kugelmann, Heinrich; Arkenau-Marić, Elisabeth, Abuse-proofed dosage form.
  10. Jurgen Zeidler DE; Jorg Rosenberg DE; Werner Maier DE; Jorg Neumann DE, Cleavable solid dosage forms and method for the production thereof.
  11. Forse Sidney F. (Macclesfield GB2) Rowe Raymond C. (Congleton GB2), Coated colored intagliated articles.
  12. Roswall Stig (Soborg DKX) Thorhus Lene B. (Holte DKX), Combination formulation.
  13. Lang Siegfried (Ludwigshafen DEX), Direct tableting auxiliary.
  14. Junichi Miyabe JP; Kiyoshi Morimoto JP; Yuji Iwase JP; Shigemitsu Miura JP; Eiji Hayakawa JP; Kunio Ito JP, Dividable tablet and press-through pack.
  15. Zierenberg, Bernd; Gupte, Arun R., Divisible pharmaceutical tablet with delayed active ingredient release.
  16. Parikh, Nilesh H.; Hite, William Crawford; Patel, Bhavesh R., Divisible tablet and associated methods.
  17. Arkenau-Marić, Elisabeth; Bartholomaeus, Johannes; Ziegler, Iris; Haupts, Marcel, Dosage form with impeded abuse.
  18. Barnscheid, Lutz; Galia, Eric, Hot-melt extruded pharmaceutical dosage form.
  19. Cefali, Eugenio A.; Bova, David J., Intermediate release nicotinic acid compositions for treating hyperlipidemia.
  20. Cefali, Eugenio A., Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics.
  21. Sancoff Gregory E. (Rancho Santa Fe CA) Doyle Mark C. (San Diego CA), Liquid delivery device.
  22. Pedersen Arne M. (Vanlose DKX) Jensen Jens R. (Stenlose DKX), Method for preparing a pharmaceutical controlled release composition.
  23. Solomon, Lawrence; Kaplan, Allan S., Method of administering a partial dose using a segmented pharmaceutical tablet.
  24. Bova David J., Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night.
  25. Cefali, Eugenio A.; Bova, David J., Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia.
  26. Becker John W. (Littleton CO), Multi-fractionable tablet structure.
  27. Barnscheid, Lutz; Wening, Klaus; Pätz, Jana; Geissler, Anja, Multiparticles safeguarded against ethanolic dose-dumping.
  28. Bova David J., Nicotinic acid compositions for treating hyperlipidemia and related methods therefor.
  29. Bova, David J, Nicotinic acid compositions for treating hyperlipidemia and related methods therefor.
  30. Barnscheid, Lutz; Galia, Eric; Schwier, Sebastian; Bertram, Ulrike; Geissler, Anja; Griessmann, Kornelia; Bartholomäus, Johannes, Oxidation-stabilized tamper-resistant dosage form.
  31. Wang, Yvonne, Pet food.
  32. Jans, Eugeen Marie Jozef; Kiekens, Filip René Irena; Voorspoels, Jody Firmin Marceline; Faure, Anne; Arkenau-Maric, Elisabeth; Barnscheid, Lutz; Bartholomäus, Johannes; Frevel, Marc; Galia, Eric; Ziegler, Iris; Schüssele, Andrea, Pharmaceutical dosage form.
  33. Jans, Eugeen Marie Jozef; Kiekens, Filip René Irena; Voorspoels, Jody Firmin Marceline; Faure, Anne; Ziegler, Iris; Arkenau-Maric, Elisabeth; Barnscheid, Lutz; Bartholomäus, Johannes; Frevel, Marc; Galia, Eric; Schüessele, Andrea, Pharmaceutical dosage form.
  34. Schonewille,Gerrit, Pharmaceutical tablet.
  35. Guyer Thomas L. (Richland MI) Franz Robert M. (Otsego MI), Polymeric material as a disintegrant in a compressed tablet.
  36. Haupts, Marcel, Preparation of a powdery pharmaceutical composition by means of an extruder.
  37. Faure, Anne; Voorspoels, Jody Firim Marceline; Mertens, Roel Jos M.; Kiekens, Filip René Irena, Process for the preparation of a solid dosage form, in particular a tablet, for pharmaceutical use and process for the preparation of a precursor for a solid dosage form, in particular a tablet.
  38. Arkenau, Elisabeth; Bartholomāus, Johannes, Process for the production of an abuse-proofed solid dosage form.
  39. Arkenau-Maric, Elisabeth; Bartholomäus, Johannes; Kugelmann, Heinrich, Process for the production of an abuse-proofed solid dosage form.
  40. Iida Yoshimitsu (Saitama JPX) Yoshizawa Atsuko (Tokyo JPX) Kujirai Tatuo (Saitama JPX) Ogasawara Toshichika (Tokyo JPX), Prolonged-action multiple-layer tablets.
  41. Katakuse, Yoshimitsu; Kohlmeyer, Manfred; Taike, Takashi; Wagner, Robert Frank; Yamato, Fujiki, Solid oral dosage forms of valsartan.
  42. Robert Frank Wagner ; Yoshimitsu Katakuse JP; Takashi Taike JP; Fujiki Yamato JP; Manfred Kohlmeyer CH, Solid oral dosage forms of valsartan.
  43. Wagner Robert Frank ; Katakuse Yoshimitsu,JPX ; Taike Takashi,JPX ; Yamato Fujiki,JPX ; Kohlmeyer Manfred,CHX, Solid oral dosage forms of valsartan.
  44. Glassman Jacob A. (1680 Michigan Ave. Miami Beach FL 33139), Super-fast-starting-sustained release tablet.
  45. Gervais, Sonia; Smith, Damon; Contamin, Pauline; Ouzerourou, Rachid; Ma, My Linh, Sustained drug release composition.
  46. Gervais, Sonia; Smith, Damon; Contamin, Pauline; Ouzerourou, Rachid; Ma, My Linh, Sustained drug release composition.
  47. Gervais, Sonia; Smith, Damon; Contamin, Pauline; Ouzerourou, Rachid; Ma, My Linh, Sustained drug release compositions.
  48. Sakamoto Teruo (Osaka JPX) Kawai Sadao (Osaka JPX) Noda Kinzaburo (Hyogo JPX) Takeda Toyohiko (Hyogo JPX) Ogura Toshihiro (Hyogo JPX), Sustained-release preparation of pinacidil.
  49. Hite William Crawford ; Parikh Nilesh H. ; Jaigirdar Masihuddin Ahmed, Tablet.
  50. Ikonte, Chioma J., Tablet.
  51. Scapinelli Bruno (Lamorlaye FRX), Tablet having the shape of a capsule, process and device for its preparation.
  52. Toya Kazutoshi (Takatsuki JPX) Uchiyama Nobuo (Toyonaka JPX) Miura Seiko (Takatsuki JPX) Mitsunaga Takayoshi (Ibaraki JPX) Tobiki Hisao (Kobe JPX), Tablets having clear impressed marks and method for making same.
  53. Barnscheid, Lutz; Schwier, Sebastian; Bartholomäus, Johannes, Tamper resistant dosage form comprising an anionic polymer.
  54. Barnscheid, Lutz; Geiβler, Anja; Wening, Klaus; Strauch, Stefanie; Pätz, Jana; Schwier, Sebastian, Tamper resistant dosage form with bimodal release profile.
  55. Friedrich, Ingo; Fuhrherr, Richard; Möschter, Silke; Wengner, Simone, Tamper resistant immediate release capsule formulation comprising tapentadol.
  56. Barnscheid, Lutz; Redmer, Jessica; Schwier, Sebastian, Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer.
  57. Barnscheid, Lutz; Geiβler, Anja; Wening, Klaus; Pätz, Jana, Tamper-resistant dosage form containing one or more particles.
  58. Wening, Klaus; Geiβler, Anja; Denker, Jana; Barnscheid, Lutz, Tamper-resistant dosage form with immediate release and resistance against solvent extraction.
  59. Schwier, Sebastian; Haupts, Marcel; Barnscheid, Lutz; Pätz, Jana, Tamper-resistant tablet providing immediate drug release.
  60. Barnscheid, Lutz; Galia, Eric; Geißler, Anja; Pätz, Jana; Schwier, Sebastian; Baronsky-Probst, Julia, Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc.
  61. Gervais, Sonia; Smith, Damon; Rahmouni, Miloud; Contamin, Pauline; Ouzerourou, Rachid; Ma, My Linh; Ferrada, Angela; Soulhi, Fouzia, Trazodone composition for once a day administration.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로